{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T07:02:23Z","timestamp":1794898943542,"version":"4.9.1"},"reference-count":36,"publisher":"MDPI AG","issue":"20","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NHS Lothian and Merck"},{"name":"Sharp and Dohme"},{"name":"Macmillan and the Scottish Government"},{"name":"NHS Research Scotland Career Researcher Clinician"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background\/Objectives: Lung cancer is the commonest cause of cancer death worldwide. Treatment efficacy is improving, but treatment rates remain low. We aimed to assess the impact of tri-modality early prehabilitation (single in-person interventions by a senior doctor in palliative\/supportive care, physiotherapist and dietitian) on patients with a radiological diagnosis of lung cancer. Methods: Patients were approached as soon as they were told they had a radiological diagnosis of lung cancer. Prehabilitation took place in parallel with a patient\u2019s investigative pathway for lung cancer. Routine data for admissions and survival was assessed retrospectively for prehabilitation patients and compared to an appropriate group of historical controls. Results: A total of 97 patients with stage 3 or 4 lung cancer underwent prehabilitation and were compared to 199 historical controls. There were no obvious statistical differences in gender or age between the cohorts. There was a trend towards reduced mean length of stay (LOS) from 7.6 days to 2.6 days in the patients who underwent all three interventions and from 7.6 days to 3 days in all comers (p = 0.053), with a significantly shorter admission in those who were admitted (p = 0.0014). There was a reduction in time spent in hospital from 486 days to 172 days per 100 patients receiving prehabilitation (a saving of 3.1 days per patient participating). Survival appeared to improve 6 months after diagnosis, at 61% in the prehabilitation cohort (95% CI: 51.8\u201372.0%, p = 0.029) vs. 47.7% in the historical controls (95% CI: 41.3\u201355.2%, p = 0.029). Life-prolonging treatment rates in stage 4 disease increased from 26% to 42% and all-comer best supportive care rates reduced from 45% to 28%. Conclusions: Early prehabilitation appears to reduce time spent in hospital. It may also improve treatment rates and short-term survival in patients being investigated for lung cancer.<\/jats:p>","DOI":"10.3390\/cancers17203329","type":"journal-article","created":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T07:29:38Z","timestamp":1760599778000},"page":"3329","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Multidisciplinary Prehabilitation Reduces Hospitalization Time and Suggests Improved Survival in Patients with Radiologically Diagnosed Lung Cancer"],"prefix":"10.3390","volume":"17","author":[{"given":"Iain","family":"Phillips","sequence":"first","affiliation":[{"name":"Edinburgh Cancer Centre, Western General Hospital, Edinburgh EH4 2XU, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caleb","family":"McDougall","sequence":"additional","affiliation":[{"name":"Edinburgh Cancer Centre, Western General Hospital, Edinburgh EH4 2XU, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abi","family":"Walton","sequence":"additional","affiliation":[{"name":"Edinburgh Cancer Centre, Western General Hospital, Edinburgh EH4 2XU, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Stares","sequence":"additional","affiliation":[{"name":"Edinburgh Cancer Centre, Western General Hospital, Edinburgh EH4 2XU, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Hall","sequence":"additional","affiliation":[{"name":"Edinburgh Cancer Centre, Western General Hospital, Edinburgh EH4 2XU, UK"},{"name":"St John\u2019s Hospital, Livingston EH54 6PP, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Grecian","sequence":"additional","affiliation":[{"name":"St John\u2019s Hospital, Livingston EH54 6PP, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"O\u2019Brien","sequence":"additional","affiliation":[{"name":"St John\u2019s Hospital, Livingston EH54 6PP, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Mencnarowski","sequence":"additional","affiliation":[{"name":"Edinburgh Cancer Centre, Western General Hospital, Edinburgh EH4 2XU, UK"},{"name":"St John\u2019s Hospital, Livingston EH54 6PP, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"MacCormick","sequence":"additional","affiliation":[{"name":"St John\u2019s Hospital, Livingston EH54 6PP, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin","family":"McLean","sequence":"additional","affiliation":[{"name":"St John\u2019s Hospital, Livingston EH54 6PP, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Higgins","sequence":"additional","affiliation":[{"name":"St John\u2019s Hospital, Livingston EH54 6PP, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debbie","family":"McMillan","sequence":"additional","affiliation":[{"name":"St John\u2019s Hospital, Livingston EH54 6PP, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colette","family":"Reid","sequence":"additional","affiliation":[{"name":"Edinburgh Cancer Centre, Western General Hospital, Edinburgh EH4 2XU, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0474-7526","authenticated-orcid":false,"given":"Lindsey","family":"Allan","sequence":"additional","affiliation":[{"name":"Department of Nutrition and Dietetics, Royal Surrey NHS Foundation Trust, Guildford GU2 7XX, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5540-4189","authenticated-orcid":false,"given":"Benjamin Jia Liang","family":"Lim","sequence":"additional","affiliation":[{"name":"Edinburgh Medical School, University of Edinburgh Medical School, Edinburgh EH16 4UU, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Barrie","sequence":"additional","affiliation":[{"name":"Edinburgh Cancer Centre, Western General Hospital, Edinburgh EH4 2XU, UK"},{"name":"St John\u2019s Hospital, Livingston EH54 6PP, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"115303","DOI":"10.1016\/j.ejca.2025.115303","article-title":"Four decades of lung cancer: Trends in comorbidities and causes of death in a nationwide Danish cohort","volume":"218","author":"Borg","year":"2025","journal-title":"Eur. J. Cancer"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s12032-010-9534-z","article-title":"Comparison of PG-SGA, SGA and body-composition measurement in detecting malnutrition among newly diagnosed lung cancer patients in stage IIIB\/IV and benign conditions","volume":"28","author":"Li","year":"2011","journal-title":"Med. Oncol."},{"key":"ref_3","unstructured":"(2025, May 01). Lung Cancer Survival Statistics. Available online: http:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/lung-cancer\/survival#heading-Zero."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1513\/AnnalsATS.201701-030OC","article-title":"Comorbidity Profiles and Their Effect on Treatment Selection and Survival among Patients with Lung Cancer","volume":"14","author":"Gould","year":"2017","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1093\/advances\/nmac070","article-title":"Current Insights in Nutrition Assessment and Intervention for Malnutrition or Muscle Loss in People with Lung Cancer: A Narrative Review","volume":"13","author":"Kiss","year":"2022","journal-title":"Adv. Nutr."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1200\/JCO.21.01308","article-title":"Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer","volume":"40","author":"Spigel","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1200\/JCO.21.00174","article-title":"Five-Year Outcomes with Pembrolizumab Versus Chemotherapy for Metastatic Non-Small-Cell Lung Cancer with PD-L1 Tumor Proportion Score \u2265 50","volume":"39","author":"Reck","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1056\/NEJMoa2304594","article-title":"Overall Survival with Osimertinib in Resected","volume":"389","author":"Tsuboi","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1200\/JCO.24.00581","article-title":"Lorlatinib Versus Crizotinib in Patients with Advanced","volume":"42","author":"Solomon","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1056\/NEJMoa2310532","article-title":"Alectinib in Resected","volume":"390","author":"Wu","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1056\/NEJMoa1801005","article-title":"Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer","volume":"378","author":"Gandhi","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_12","unstructured":"Navani, N., Conibear, J., and West, D. (2025, May 01). State of the Nation Report 2024, an Audit of Care Received by Patients Diagnosed with Lung Cancer in England and Wales During 2022. Available online: https:\/\/www.lungcanceraudit.org.uk\/wp-content\/uploads\/2024\/04\/NLCA-State-of-the-Nation-Report-2024.pdf."},{"key":"ref_13","unstructured":"Macmillan (2025, May 01). Prehabilitation for People with Cancer. Available online: https:\/\/www.macmillan.org.uk\/healthcare-professionals\/cancer-pathways\/prehabilitation."},{"key":"ref_14","unstructured":"Scottish Government (2022, October 05). Key Principles for Implementing Cancer Prehabilitation Across Scotland, Available online: https:\/\/www.prehab.nhs.scot\/for-professionals\/key-principles\/."},{"key":"ref_15","unstructured":"Scottish Government (2023). Cancer Strategy for Scotland 2023\u20132033."},{"key":"ref_16","unstructured":"Scottish Government (2023). Cancer Action Plan for Scotland 2023\u20132026."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/j.jtcvs.2017.10.151","article-title":"The impact of enhanced recovery after surgery (ERAS) protocol compliance on morbidity from resection for primary lung cancer","volume":"155","author":"Rogers","year":"2018","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1177\/0148607114523451","article-title":"ERAS\u2014enhanced recovery after surgery: Moving evidence-based perioperative care to practice","volume":"38","author":"Ljungqvist","year":"2014","journal-title":"J. Parenter. Enter. Nutr."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e081164","DOI":"10.1136\/bmj-2024-081164","article-title":"Relative efficacy of prehabilitation interventions and their components: Systematic review with network and component network meta-analyses of randomised controlled trials","volume":"388","author":"McIsaac","year":"2025","journal-title":"BMJ"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1136\/spcare-2024-004869","article-title":"Early prehabilitation reduces admissions and time in hospital in patients with newly diagnosed lung cancer","volume":"15","author":"Phillips","year":"2024","journal-title":"BMJ Support. Palliat. Care"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"100445","DOI":"10.1016\/j.esmoop.2022.100445","article-title":"Biomarkers of systemic inflammation predict survival with first-line immune checkpoint inhibitors in non-small-cell lung cancer","volume":"7","author":"Stares","year":"2022","journal-title":"ESMO Open"},{"key":"ref_22","first-page":"3833","article-title":"Validation of the Scottish Immunotherapy Prognostic Score (SIPS) in NSCLC patients treated with first-line pembrolizumab","volume":"16","author":"Phillips","year":"2024","journal-title":"ESMO Open"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1056\/NEJMoa1000678","article-title":"Early palliative care for patients with metastatic non-small-cell lung cancer","volume":"363","author":"Temel","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_24","first-page":"10499091241300530","article-title":"Early Palliative Care in Advanced Non-Small Cell Lung Cancer Patients: A Meta-Analysis","volume":"42","author":"Liu","year":"2024","journal-title":"Am. J. Hosp. Palliat. Care"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.clon.2020.07.020","article-title":"Supportive Care: An Indispensable Component of Modern Oncology","volume":"32","author":"Berman","year":"2020","journal-title":"Clin. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"510","DOI":"10.12968\/ijpn.2018.24.10.510","article-title":"Multi-professional-delivered enhanced supportive care improves quality of life for patients with incurable cancer","volume":"24","author":"Monnery","year":"2018","journal-title":"Int. J. Palliat. Nurs."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1136\/spcare-2023-004231","article-title":"Enhanced supportive care: Prospective cohort study of oncology patients and caregivers","volume":"14","author":"Taylor","year":"2024","journal-title":"BMJ Support. Palliat. Care"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.clon.2023.01.015","article-title":"The Rise of Supportive Oncology: A Revolution in Cancer Care","volume":"35","author":"Berman","year":"2023","journal-title":"Clin. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Kircher, C.E., Hanna, T.P., Tranmer, J., Goldie, C.E., Ross-White, A., Moulton, E., Flegal, J., and Goldie, C.L. (2025). Defining \u201cearly palliative care\u201d for adults diagnosed with a life-limiting illness: A scoping review. BMC Palliat. Care, 24.","DOI":"10.1186\/s12904-025-01712-7"},{"key":"ref_30","unstructured":"Tiberini, R., and Richardson, H. (2015). Rehabilitative Palliative Care: Enabling People to Live Fully Until They Die, Hospice UK."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"108572","DOI":"10.1016\/j.lungcan.2025.108572","article-title":"Feasibility, acceptability and clinical outcomes of a real-world, regional lung cancer prehabilitation programme for patients undergoing curative intent radiotherapy","volume":"204","author":"Gourlay","year":"2025","journal-title":"Lung Cancer"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1365-277X.2011.01189.x","article-title":"Simple nutritional intervention in patients with advanced cancers of the gastrointestinal tract, non-small cell lung cancers or mesothelioma and weight loss receiving chemotherapy: A randomised controlled trial","volume":"24","author":"Baldwin","year":"2011","journal-title":"J. Hum. Nutr. Diet."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.clon.2019.07.020","article-title":"Stage III Non-small Cell Lung Cancer Management in England","volume":"31","author":"Adizie","year":"2019","journal-title":"Clin. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Stares, M., Brown, L., Abhi, D., and Phillips, I. (2024). Prognostic Biomarkers of Systemic Inflammation in Non-Small Cell Lung Cancer: A Narrative review of challenges and opportunities. Cancers, 16.","DOI":"10.3390\/cancers16081508"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jhin.2020.12.027","article-title":"Bed-days and costs associated with the inpatient burden of healthcare-associated infection in the UK","volume":"114","author":"Manoukian","year":"2021","journal-title":"J. Hosp. Infect."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.clon.2022.08.028","article-title":"Prehabilitation and Rehabilitation for Patients with Lung Cancer: A Review of Where we are Today","volume":"34","author":"Burnett","year":"2022","journal-title":"Clin. Oncol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/20\/3329\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T07:42:14Z","timestamp":1760600534000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/20\/3329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":36,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["cancers17203329"],"URL":"https:\/\/doi.org\/10.3390\/cancers17203329","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,15]]}}}